Nanobiotix (NBTX) stock rises as the firm reports 85% disease control in an early-stage trial for JNJ-1900, a cancer treatment developed with J&J (JNJ). Read more here.
NetSol Technologies, Inc. ( NASDAQ: NTWK) Q4 2025 Earnings Call September 30, 2025 9:00 AM EDT ...
Q3 2025 Earnings Call Transcript September 25, 2025 Concentrix Corporation misses on earnings expectations. Reported EPS is $2.78 EPS, expectations were $2.88. Operator: Good day, everyone, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback